Quest Diagnostics, Inc. (DGX)
A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.
Recs
Quest Diagnostices has het bottom is is beginning to rebound. this is the prime time to invest.
Recs
Recs
Exorcised UNH, assimilated Ameripath, mid-year guidance of 6.1 to 6.2 B for 2007 will end up at 6.6/6.7, operating margins are going back up, Ameripath should fuel growth for 2008 and beyond, and now, I've read that the sales reps can now concentrate on new business, instead of keeping old.
Recs
Long-term value play
Recs
Performed relatively well during this bear market. As the market rebounds a bit, DGX won't rebound as fast as it has less "room to run" than many others in the SP500.
Recs
Quest will continue to grow as out-sourcing of testing will not stop. The stock is a little bit expensive but I expect earnings growth to be better than consensus.
Recs
Quest lost a major sales outlet 7% of total sales but the company was trying to shed low margin customers and, while large, the lost contract would have been minimal margin
Recs
DGX does medical diagnostics tests. As the baby boomers retire more and more medical diagnostic tests will be done. Furthermore, it is cheaper for insurance companies to do a test and screen early for a disease, ie. cancer, than wait and pay for treatment later. Therefore insurance companies will push more diagnostic tests and push demand. Furthermore, investors are not liking the purchase today of a smaller competitor and have dropped the share price 5% today. As DGX consolidates by eating up competitors it gets stronger in the long term, so I will buy on this dip in price.
Recs
Reference labs tend to fair well when cost control comes into play
Recs
Seems to be cheap compared to Lab Corp - time will tell.
Recs
QUEST DIAGNOSTICS.......,When I hear that name,it hits home like an old familiar tune. This is probably one of the most well managed companies of it's kind. You might look at it as a role model that all the others should pattern themselves after. When all the dust clears from this mess we've put ourselves in, Quest will be outstanding. Great financial history.
Recs
With the waxing and waining of winter ailments, this one will rise to the occasion.
Recs
The Flu & VRML will make this move higher.
Recs
Market has rightly punished price for loss of customer, but valuation seems so low to me that given favorable demographics should be a good long term bet...fwiw, folks in the doctor's office i know greatly prefer their service to that of their competition.
Recs
Quest Diagnostics has strength and weakness but it will be interesting to follow through on this time chain.
Recs
Dog Star Theory from Jim Jubak
Recs
Underperformed the previous quarter and will steadily rise after irrational fear of healthcare legislation subsides
Recs
nothing like a monopolistic oligopoly
Recs
Valuation shows very high returns on capital with or without United Healthcare. Price should improve over time once bad news is digested
Recs
Baby boomer population is getting old and I expect the lab testing to increase in the future (with Quest being the top dog)...I bought this in early Oct 2006 when there was a major drop in price (over 10%) with the news of the loss of the UnitedHealthcare contract. Hoping I bought low and will reap the benefits.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 73 1 2 3 4 Next »